Association between facial cutaneous coccidioidomycosis and meningitis.
The skin is frequently a site of extrapulmonary dissemination in patients with coccidioidomycosis. Clinical experience in an endemic area suggests an association between facial cutaneous coccidioidomycosis and meningitis. Awareness of this association is important because coccidioidal meningitis is the most ominous site of spread in coccidioidomycosis. In this study, we assess whether cutaneous dissemination involving the face is associated with meningitis to a greater degree than that limited to the body. We retrospectively reviewed the medical records of 201 patients from 1987 to 1996 with disseminated coccidioidomycosis and found 30 patients with cutaneous involvement. Their mean age was 29.5 +/- 11.6 years; 20 patients were male; 14 were African American, 12 were Hispanic, 3 were white, and 1 was Asian. Nineteen patients had facial involvement, and 11 had isolated body involvement. Meningitis developed in 11 patients, 10 with facial involvement and 1 with only body involvement. Patients with facial lesions were more likely to have meningitis (odds ratio, 11.1; 95% confidence interval, 1.1 to 529, P = .023). The identification of a subgroup of patients at significant risk of developing meningitis may allow earlier detection and perhaps improved management of patients with meningeal disease.
Department of Internal Medicine, Kern Medical Center, Bakersfield, California, USA.
E L
EL
Arsura
W B
WB
Kilgore
J W
JW
Caldwell
J C
JC
Freeman
H E
HE
Einstein
R H
RH
Johnson
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003047:Coccidioidomycosis / Q000150:complications* / Q000188:drug therapy; D016001:Confidence Intervals; D003881:Dermatomycoses / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D005148:Facial Dermatoses / Q000150:complications* / Q000188:drug therapy; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D008297:Male; D016921:Meningitis, Fungal / Q000150:complications* / Q000188:drug therapy; D016017:Odds Ratio; D012189:Retrospective Studies
D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole